Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252902 · ClinicalTrials.gov registry record · Phase 1
Emergency Department Initiated Tobacco Treatment (EDITT)
A Phase 1 study of Tobacco Use, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00252902 is a Phase 1 study of Tobacco Use that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 75 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00252902, a Phase 1 study of Tobacco Use, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the study is to refine the intervention protocols for two ED-initiated tobacco interventions and to assess the magnitude of the effect size that can be expected. We expect the intervention groups to have greater sustained abstinence, point-prevalence abstinence, and motivation to change when compared to the treatment as usual group at 1- and 3-month follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Behavior change counseling
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252902
The ClinicalTrials.gov registry entry for NCT00252902 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (80% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Behavior change counseling is the first listed.
NCT00252902 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT00252902 about?
NCT00252902 is a clinical study titled "Emergency Department Initiated Tobacco Treatment (EDITT)". The primary purpose of the study is to refine the intervention protocols for two ED-initiated tobacco interventions and to assess the magnitude of the effect size that can be expected. We expect the intervention groups to have greater sustained abstinence, point-prevalence abstinence, and motivation...
What is the current status of trial NCT00252902?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2005-12. Estimated completion is 2007-12.
What conditions does trial NCT00252902 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT00252902?
The interventions under investigation include: Behavior change counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00252902?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252902 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Oral Cannabidiol for Tobacco Cessation
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
COMPLETED · Phase 1
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.